Elizabeth A. Sakach
MD
Dr. Sakach specializes in the treatment of patients with breast cancer.
Titles and Roles
- Assistant Professor, Department of Hematology and Medical Oncology
- Emory University School of Medicine
- Medical Oncologist
- Breast Cancer
- Phase I Clinical Trials Unit
Biography
Elizabeth A. Sakach, MD, is assistant professor in the Department of Hematology and Medical Oncology at Emory University School of Medicine. A medical oncologist, Dr. Sakach is passionate about treating patients with breast cancer. Her goal is to meet her patients with empathy and understanding, offering state-of-the-art care through a shared decision making approach. She joined the Glenn Family Breast Center at Winship Cancer Institute in 2023.
Dr. Sakach is a member of American Society of Clinical Oncology.
Education
Dr. Sakach earned her medical degree from Texas A&M College of Medicine in College Station, Texas. She completed her residency in internal medicine and fellowship in hematology and medical oncology at Emory University School of Medicine in Atlanta, Georgia, where she served as chief fellow in her final year. She completed a fellowship in cancer drug development with the FDA-AACR through the Oncology Educational Fellowship program.
Research
Dr. Sakach's research is focused on the investigation of mechanisms of resistance and novel therapeutics for patients with advanced breast cancer. She serves as principal investigator for several therapeutic trials for patients with breast malignancies at Winship Cancer Institute.
Publications
Dr. Sakach has presented her research on breast cancer at national meetings and has published her work in peer-reviewed journals including Journal of Clinical Oncology and Clinical Breast Cancer.
Publications Publication Date
Awards
Dr. Sakach’s awards and honors include:
- Young Investigator Award, Conquer Cancer, The ASCO Foundation, 2023
- FDA-AACR Oncology Educational Fellowship, 2022-2023
- Participant at ASCO/AACR Methods in Clinical Cancer Research Workshop, 2022
- Served on advisory board for FDA/AACR’s Oncology Center of Excellence: Project Renewal, 2022